Telesis Bio Inc. Reports Third Quarter 2022 Financial Results
November 08, 2022 at 16:10 PM EST
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021
-- BioXp® Kit Revenue increased to $884k, or 69% in 3QFY22 over 3QFY2021
-- Increases revenue guidance to $23 million to $25 million for the full year fiscal 2022
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: DNAY), a company enabling customers to accelerate the reading and writing of biology, today reported financial results and business highlights for the third quarter ended September 30, 2022.
“We are continuing to execute to our plan of being the leader in benchtop automation for synthetic biology, multiomics and next gen sequencing,” said Todd R. Nelson, Ph.D., CEO and Founder of Telesis Bio.
Dr. Nelson continued, "Beginning in Q1 of 2023 we will release additional BioXp® kits that will enable scientists to begin the cloning, amplification, and mRNA synthesis process from the customer’s own linear DNA or plasmid DNA. We believe providing scientists the flexibility to begin with their own materials as an optional starting point will further expand the utility, speed, and impact of our systems. This will allow us to deliver increased value to our customers and to access a significantly larger portion of the customer base. The new kits will also position us well to take increased share of the synthetic biology and multiomics markets, while at the same time growing our revenue, and improving our margins.”
THIRD QUARTER 2022 FINANCIAL RESULTS
Updated 2022 Financial Guidance
Webcast and Conference Call Information
The press release and live audio webcast can be accessed via the Investor section of Telesis Bio’s website at www.telesisbio.com. The conference call can be accessed by registering at the following link: https://register.vevent.com/register/BI49e33f1c6b4f43358b820bbfd7b78ed6
Once registered, participants can dial in with an assigned personal PIN number or select the ‘Call Me’ option for an instant dial to your phone. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for replay on Telesis Bio’s website for 30 days.
About Telesis Bio
Telesis Bio, the Telesis Bio logo, Gibson Assembly, and BioXp are trademarks of Telesis Bio Inc.
Telesis Bio Inc.